Dorian Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 8

Dorian Therapeutics General Information

Description

Developer of novel therapeutics designed to rejuvenate cells and tissues. The company offers small-molecule therapeutics and tools for cellular therapies, enabling medical practitioners to treat age-related diseases and improve the effectiveness of adoptive immunotherapy.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 733 Industrial Road
  • San Carlos, CA 94070
  • United States
+1 (650)
Primary Industry
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 733 Industrial Road
  • San Carlos, CA 94070
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dorian Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dorian Therapeutics‘s full profile, request access.

Request a free trial

Dorian Therapeutics Patents

Dorian Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026226574-A1 Usp16 inhibitors and methods of use thereof Pending 21-Apr-2025
WO-2022109341-A1 Compounds for treatment of osteoarthritis Inactive 20-Nov-2020
AU-2020340447-A1 Methods and compositions for modulating cellular aging Inactive 29-Aug-2019
CA-3152786-A1 Methods and compositions for modulating cellular aging Pending 29-Aug-2019
EP-4022040-A1 Methods and compositions for modulating cellular aging Inactive 29-Aug-2019 C12N15/113
To view Dorian Therapeutics’s complete patent history, request access »

Dorian Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dorian Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Dorian Therapeutics‘s full profile, request access.

Request a free trial

Dorian Therapeutics FAQs

  • When was Dorian Therapeutics founded?

    Dorian Therapeutics was founded in 2018.

  • Where is Dorian Therapeutics headquartered?

    Dorian Therapeutics is headquartered in San Carlos, CA.

  • What is the size of Dorian Therapeutics?

    Dorian Therapeutics has 8 total employees.

  • What industry is Dorian Therapeutics in?

    Dorian Therapeutics’s primary industry is Biotechnology.

  • Is Dorian Therapeutics a private or public company?

    Dorian Therapeutics is a Private company.

  • What is Dorian Therapeutics’s current revenue?

    The current revenue for Dorian Therapeutics is .

  • How much funding has Dorian Therapeutics raised over time?

    Dorian Therapeutics has raised $150K.

  • Who are Dorian Therapeutics’s investors?

    Blumberg Capital, Boom Capital Ventures, MBC BioLabs, Pacific 8 Ventures, and StartX (US) are 5 of 7 investors who have invested in Dorian Therapeutics.

  • When was Dorian Therapeutics acquired?

    Dorian Therapeutics was acquired on 21-May-2025.

  • Who acquired Dorian Therapeutics?

    Dorian Therapeutics was acquired by Altos Labs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process